GDF-15, iron, and inflammation in early chronic kidney disease among elderly patients

International Urology and Nephrology

Volumn 48, Issue 6, 2016, Pages 839-844

  Lukaszyk, Ewelina ^a   Lukaszyk, Mateusz ^a   Koc Zorawska, Ewa ^a   Bodzenta Lukaszyk, Anna ^a   Malyszko, Jolanta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Chronic kidney disease; GDF 15; Hepcidin; Inflammation; Iron

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GROWTH DIFFERENTIATION FACTOR 15; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 6; IRON; SOLUBLE TRANSFERRIN RECEPTOR; TRANSFERRIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; GDF15 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN;

ADULT; AGED; ANEMIA; ARTICLE; CHEMICAL PARAMETERS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTIMATED GLOMERULUS FILTRATION RATE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INFLAMMATION; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; PREDICTION; PROTEIN BLOOD LEVEL; STAGING; TRANSFERRIN SATURATION; AGE; BLOOD; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; COMPLICATION; FEMALE; MALE; METABOLISM; MIDDLE AGED; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOMARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; GROWTH DIFFERENTIATION FACTOR 15; HEMOGLOBINS; HEPCIDINS; HUMANS; INFLAMMATION; INTERLEUKIN-6; IRON; MALE; MIDDLE AGED; RECEPTORS, TRANSFERRIN; RENAL INSUFFICIENCY, CHRONIC; TRANSFERRINS;

EID: 84962195217     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-016-1278-z     Document Type: Article

References (22)

1. Lindeman RD, Tobin J, Shock NW (1984) Association between blood pressure and the rate of decline in renal function with age. Kidney Int 26:861–868
2. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS (2003) Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third national health and nutrition examination survey. Am J Kidney Dis 41:1–12
3. Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Dobrzycki S (2010) Prevalence of chronic kidney disease in elderly patients with normal serum creatinine levels undergoing percutaneous coronary interventions. Gerontology 56:51–54
4. Tanno T, Noel P, Miller JL (2010) Growth differentiation factor 15 in erythroid health and disease. Curr Opin Hematol 17:184–190
5. Tanno T, Bhanu NV, Oneal PA, Goh SH, Staker P, Lee YT, Moroney JW, Reed CH, Luban NL, Wang RH, Eling TE, Childs R, Ganz T, Leitman SF, Fucharoen S, Miller JL (2007) High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 13:1096–1101
6. Ho JE, Hwang SJ, Wollert KC, Larson MG, Cheng S, Kempf T, Vasan RS, Januzzi JL, Wang TJ, Fox CS (2013) Biomarkers of cardiovascular stress and incident chronic kidney disease. Clin Chem 59:1613–1620
7. Fuchs T, Trollor JN, Crawford J, Brown DA, Baune BT, Samaras K, Campbell L, Breit SN, Brodaty H, Sachdev P, Smith E (2013) Macrophage inhibitory cytokine-1 is associated with cognitive impairment and predicts cognitive decline—the Sydney Memory and Aging Study. Aging Cell 12:882–889
8. KDIGO (2012) Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013(3):1–150
9. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RC, Fairlie WD, Por SB, Robbins JM, Breit SN (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA 94:11514–11519
10. Breit SN, Carrero JJ, Tsai VW, Yagoutifam N, Luo W, Kuffner T, Bauskin AR, Wu L, Jiang L, Barany P, Heimburger O, Murikami MA, Apple FS, Marquis CP, Macia L, Lin S, Sainsbury A, Herzog H, Law M, Stenvinkel P, Brown DA (2012) Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease. Nephrol Dial Transplant 27:70–75
11. Theurl I, Finkenstedt A, Schroll A, Nairz M, Sonnweber T, Bellmann-Weiler R, Theurl M, Seifert M, Wroblewski VJ, Murphy AT, Witcher D, Zoller H, Weiss G (2010) Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia. Br J Haematol 148:449–455
12. Waalen J, von Löhneysen K, Lee P, Xu X, Friedman JS (2011) Erythropoietin, GDF15, IL6, hepcidin and testosterone levels in a large cohort of elderly individuals with anaemia of known and unknown cause. Eur J Haematol 87:107–116
13. Lajer M, Jorsal A, Tarnow L, Parving HH, Rossing P (2010) Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy. Diabetes Care 33:1567–1572
14. Zimmers TA, Jin X, Hsiao EC, McGrath SA, Esquela AF, Koniaris LG (2005) Growth differentiation factor-15⁄macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock 23:543–548
15. Li XY, Ying J, Li JH, Zhu SL, Li J, Pai P (2015) Growth differentiation factor GDF-15 does not influence iron metabolism in stable chronic haemodialysis patients. Ann Clin Biochem 52:399–403
16. Lakhal S, Talbot NP, Crosby A, Stoepker C, Townsend AR, Robbins PA, Pugh CW, Ratcliffe PJ, Mole DR (2009) Regulation of growth differentiation factor 15 expression by intracellular iron. Blood 113:1555–1563
17. Malyszko J, Koc-Zorawska E, Malyszko JS, Glowinska I, Mysliwiec M, Macdougall IC (2013) GDF15 is related to anemia and hepcidin in kidney allograft recipients. Nephron Clin Pract 123:112–117
18. Przybyłowski P, Wasilewski G, Bachorzewska-Gajewska H, Golabek K, Dobrzycki S, Małyszko J (2014) Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure. Transplant Proc 46:2852–2855
19. Hong JH, Choi YK, Min BK, Park KS, Seong K, Lee IK, Kim JG (2015) Relationship between hepcidin and GDF15 in anemic patients with type 2 diabetes without overt renal impairment. Diabetes Res Clin Pract 109:64–70
20. Lindahl B (2013) The story of growth differentiation factor 15: another piece of the puzzle. Clin Chem 59:1550–1552
21. Adela R, Banerjee SK (2015) GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective. J Diabetes Res 2015:490842
22. Berezin AE (2015) Diabetes mellitus related biomarker: the predictive role of growth-differentiation factor-15, diabetes and metabolic syndrome: clinical research and reviews. http://dx.doi.org/10.1016/j.dsx.2015.09.01